Harnessing AI for Healthcare: A New Dawn for South Africa

By Sumona Bose

February 7, 2024

The Need for AI-Driven Healthcare Policy in South Africa

South Africa’s healthcare sector is on the brink of a transformative era, with artificial intelligence (AI) at its helm. However, the current policy frameworks are ill-equipped to foster innovation in this burgeoning field. Five key issues demand immediate attention: outdated legislation, data and algorithmic bias, workforce impact, liability dilemmas, and a dearth of AI system innovation. The establishment of a comprehensive national policy framework addressing these concerns is crucial for the safe, responsible, and regulated adoption of AI in healthcare.

The Innovation Gap: AI Patenting in South Africa

A closer look at the patenting activity within AI in South Africa reveals a stark reality. Despite the country being listed in over 9,000 AI patent applications between 2012 and 2021, only ten patents were filed from within South Africa. This disparity underscores the need for an enabling environment that promotes the development of complex cognitive and creative AI systems.

Public Sector Data: The Key to AI-Driven Healthcare

One of the significant hurdles to AI development in Africa is data availability and the costs associated with its acquisition. The National Digital Health Strategy for South Africa 2019 – 2024 identifies the development of a patient electronic health record as a key priority. This record system could provide a wealth of high-quality data to train AI systems, alleviating the significant investment and effort required to curate non-optimised data.

The concept of using public sector data to develop, train, and improve AI-enabled systems is not new. The Declaration of Cooperation on Artificial Intelligence, ratified by 25 European countries in 2018, saw member states agree to ensure better access to public sector data to fuel AI development.

However, access to sensitive health data raises privacy and security concerns. A robust legal framework or governance system is needed to encourage innovation while preserving patient privacy and security. A federated data system, where data do not leave the participating organisation but can be accessed by authorised individuals to train algorithms, could be the solution.

Conclusion

The establishment of a public sector data institution, alongside the proposed patient electronic record, could incentivise the development and deployment of AI for use in healthcare in South Africa. By providing developers with secure and safe access to health data, we can respect the rights to intellectual property and digital authenticity.

Reference url

Recent Posts

Trump drug price reform
     

A Systems Dynamics Approach to Lowering Drug Prices by 30–80% in the US

💡 Can the U.S. lower drug prices by 30–80% while improving access and preserving innovation?

President Trump’s recent Executive Order lays the groundwork for bold reforms—targeting international price gaps, PBM markups, and regulatory delays.

This article applies a systems dynamics approach to identify leverage points and feedback loops driving high U.S. drug costs—and outlines concrete, policy-based strategies to reverse them.

Explore how systemic thinking can drive sustainable, scalable change in U.S. pharmaceutical pricing.

#SyenzaNews #DrugPricing #HealthcarePolicy #SystemsThinking #PharmaInnovation

EU Multiannual Financial Framework
     

EFPIA Advocates for Stronger Life Sciences in EU Multiannual Financial Framework

💡 How can the EU strengthen its pharmaceutical sector for the future?

The EFPIA has laid out critical recommendations for the next EU Multiannual Financial Framework (2028-2034), focusing on boosting funding for life sciences research, enhancing regulatory competitiveness, and improving health data infrastructure. These insights could significantly shape the future landscape of healthcare in Europe.

Dive into the full article to learn how these recommendations aim to propel innovation and increase access to medicines across Europe!

#SyenzaNews #pharmaceuticals #healthcarepolicy

NICE health technology evaluations
        

Evolving NICE Health Technology Evaluations: Enhancing Patient Perspectives and Addressing Health Inequalities

🌟 Are you ready to embrace a new era in health technology evaluations?

Our latest article dives into the recent updates from NICE regarding the incorporation of patient perspectives and tackling health inequalities in their health technology assessments. By exploring stakeholder feedback and proposed methodologies, we uncover a shift towards more inclusive and transparent evaluations that could reshape market access and reimbursement policies in the UK healthcare system.

Don’t miss out on these vital insights that could impact your understanding of healthcare value! Read the full article [here](https://www.nice.org.uk/process/pmg36/documents/consultation-comments-and-responses).

#SyenzaNews #HealthEconomics #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.